Hydrochloric Acid

Hydrochloric Acid

SCHEMBL194776

CC(O)C[N+](C)(C)C.[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9748547 1.00
Hydrochloric Acid SCHEMBL9748760 1.00
Ammonia Solution, Strong SCHEMBL27701276 0.97 MAPT (0.44)
Water SCHEMBL9858909 0.97 MAPT (0.44)
SCHEMBL9748670 0.97
SCHEMBL193840 0.97
SCHEMBL9748138 0.97
Hydrochloric Acid SCHEMBL28871149 0.94 MAPT (0.42)
Fluoride Ion SCHEMBL1502834 0.93
Water SCHEMBL22462356 0.93 MAPT (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122004469-A Microcapsule powder rich in SN-2DHA algae oil and preparation method thereof 湖北欣和生物科技有限公司 2026-05-12 CN claimed
US-12318371-B2 Sustained-release microgel ointments with high drug loading and preparation methods and uses thereof JINAN UNIVERSITY (CN) 2025-06-03 US claimed
CN-120025480-A Modified styrene-acrylic emulsion, interior wall coating and preparation method thereof 立邦涂料(中国)有限公司 2025-05-23 CN claimed
CN-119909032-A Preparation process of hydroxypropyl methylcellulose hollow hard capsule 江苏优利胶囊有限公司 2025-05-02 CN claimed
CN-115895235-B Preparation method of aging-resistant asphalt regenerant and regenerated asphalt mixture 金华市政工程有限公司 2025-04-29 CN claimed
CN-118807000-B PVA periosteum material for bone tissue regeneration and preparation method and application thereof 祥符实验室 2024-12-24 CN claimed
CN-119100638-A Alkali-resistant glass fiber composite rib for concrete and preparation method thereof 山东斯福特实业有限公司 2024-12-10 CN claimed
CN-118807000-A PVA periosteum material for bone tissue regeneration and preparation method and application thereof 祥符实验室 2024-10-22 CN claimed
CN-115387140-B Wig fixation treatment mode and used fixation agent thereof 青岛海森林发制品集团股份有限公司 2024-08-09 CN claimed
CN-116811375-B Self-repairing fiber reinforced laminate and preparation method thereof 湖北三峡实验室 2024-07-05 CN claimed
WO-2002079259-A1 USE OF A QUATERNARY AMMONIUM ALKYL HYDROXYETHYL CELLULOSE ETHER AS A CONDITIONER FOR HAIR AND SKIN AKZO NOBEL NV (NL) 2002-10-10 WO claimed
US-H1803-H GENERATING AN IMAGE, DEVELOPMENT WITH LIQUID DEVELOPER, TRANSFERRING TO SUBSTRATE XEROX CORPORATION (US) 1999-09-07 US claimed
US-5773466-A Pharmaceutical product comprising sympathomimetic drug having therapeutic properties on the human sensibility and autocinesis in general SANTINI MAURIZIO (IT) 1998-06-30 US claimed
EP-0805898-A1 PAPER CONTAINING THERMALLY-INHIBITED STARCHES National Starch and Chemical Investment Holding Corporation (US) 1997-11-12 EP claimed
US-5672456-A CYCLODEXTRIN CHARGE CONTROL ADDITIVE, ORGANIC ALUMINUM COMPOUND CHARGE DIRECTOR; RESOLUTION XEROX CORPORATION (US) 1997-09-30 US claimed
US-5599836-A Pharmaceutical products comprising a parasympathomimetic drug having therapeutic properties in the pathology of human sensibility and the motor system in general and method of use SANTINI MAURIZIO (IT) 1997-02-04 US claimed
WO-1996023104-A1 PAPER CONTAINING THERMALLY-INHIBITED STARCHES NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) 1996-08-01 WO claimed
US-5352698-A Methods of treatment for patients suffering from Riley-Day disease SANTINI MAURIZIO (IT) 1994-10-04 US claimed
EP-0533639-A1 Pharmaceutical product comprising a parci-symphatic-mimetic drug having therapeutic properties on the human sensibility and autocinesis in general Santini, Maurizio (IT) 1993-03-24 EP claimed
EP-0171661-A1 Method of preparing cationic terpolymers and product derived therefrom AlliedSignal Inc. (US) 1986-02-19 EP claimed